Not so long ago, people used to believe that insufficient body weight and starvation was the main cause of death in the world. Nowadays, obesity and comorbidities occupy a leading position among the death causes worldwide.
Global obesity epidemic still does not receive an adequate attention. Whereas it was believed that obesity was mostly found in developed countries, today the disease spreads over the countries with low and medium level of income, especially in towns.
In fact, anorexigenic drugs containing active substance Phentermine Hydrochloride became widely popular all over the world. However, it did not manage to prevent the global obesity epidemic. Every year, we see increasing numbers of overweight people, whose only solution is surgery.
It is no secret that obesity is considered a chronic disease, affecting almost all social, economic and age groups of people. In 1995, the statistics accounted over 200 million of obese patients in the world. In 2000, this number increased up to 300 million. By 2025, the possible number of obese or overweight people is going to be over 40% of men and 50% of women.
According to different assessments, over 110 million of people suffer from obesity comorbidities all over the world. When people use Phentermine appetite suppressant, the overall health is getting normal, reducing the risk of concomitant diseases, such as:
- Cardiovascular disease
- Type 2 diabetes
- Metabolic syndrome
- Some forms of cancer
Obesity and excess body mass is a serious threat for both men and women. Although, women are diagnosed obesity more often than men are. Still, men mostly suffer from obesity of internal organs, accompanied by severe comorbidities and pathologies (including heart attack and stroke).
The World Health Organization (WHO) raised the alarm because of obesity epidemic in early 90’s of the last century. Today, WHO is cooperating with the leading universities, politicians and medical workers to help developing a global strategy on the fight against obesity.
Not all the obese patients can afford to buy Phentermine or any other anti-obesity drug. Thus, WHO believes that reduced cost on medical treatments (access to generic drugs too) is one of the measures of effective struggle against obesity.